PACKAGE LEAFLET: INFORMATION FOR THE USER …
Contact your doctor as soon as possible if: • you have severe pain or swelling in either of your legs, unexplained pains in the chest, breathlessness, an
Information, User, Leaflet, Packages, Package leaflet, Information for the user
Download PACKAGE LEAFLET: INFORMATION FOR THE USER …
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
Information, User, Leaflet, Packages, Package leaflet, Information for the user
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
Volume 10, Issue 1 Aetna OfficeLink Updates
www.aetna.comQuality health plans & benefits Healthier living Financial well-being Intelligent solutions March 2013 • Volume 10, Issue 1 Mid-America Region
Tableau Ib. Les isoenzymes CYP avec leurs substrats ...
www.appl.beTableau Ib. Les isoenzymes CYP avec leurs substrats, inhibiteurs et inducteurs Les substrats, les inhibiteurs et les inducteurs avec lesquels on s'attend à des
DRUG INDUCED QT PROLONGATION - GGC …
www.ggcprescribing.org.ukIssue 21, December 2012 Produced by NHS Greater Glasgow and Clyde Medicines Information Service . DRUG INDUCED QT PROLONGATION Prolongation of the QT interval can lead to a
2. QUALITATIVE AND QUANTITATIVE …
www.medsafe.govt.nzVersion 1.0 2 In hypercholesterolaemic patients with coronary heart disease, simvastatin slows the progression of coronary atherosclerosis, including reducing the development of new lesions and new total
2013 DoD Booklet inside - homedialyzorsunited.org
homedialyzorsunited.org2013 Dialysis of Drugs George R. Bailie, PharmD, PhD Albany College of Pharmacy and Health Sciences Nancy A. Mason, PharmD University of Michigan College of Pharmacy
Testing for HCV Infection: An Update of Guidance …
www.cdc.govEarly Release. 2 MMWR / May 7, 2013 / Vol. 62. with compensated liver disease. Boceprevir and telaprevir . interfere directly with HCV replication.
Update, Testing, Guidance, Infections, Testing for hcv infection, An update of guidance, Boceprevir